Copyright
©The Author(s) 2020.
World J Clin Oncol. Oct 24, 2020; 11(10): 844-853
Published online Oct 24, 2020. doi: 10.5306/wjco.v11.i10.844
Published online Oct 24, 2020. doi: 10.5306/wjco.v11.i10.844
Pleural effusion study | |
Pleural effusion biochemistry | |
Glucose | 92 mg/dL |
Total proteins | 4.1 g/dL |
Albumin | 2.7 g/dL |
Lactate dehydrogenase | 137 IU/L |
Cholesterol | 12 mg/dL |
Triglycerides | 182 mg/dL |
Adenosine deaminase | Not available |
Pleural effusion hemogram | |
Hemoglobin | 0.2 g/dL |
Platelets | 2600/µL |
White blood cells | 850/µL |
Neutrophils | 0 |
Lymphocytes | 800/µL |
Blood test biochemistry | |
Glucose | 86 mg/dL |
Total proteins | 6 g/dL |
Albumin | 3.5 g/dL |
Lactate dehydrogenase | 208 IU/L |
Cholesterol | 195 mg/dL |
Triglycerides | 122 mg/dL |
Microbiology study | No pathogenic microorganisms identified |
Light’s criteria | The pleural effusion meets two of three of Light’s criteria for exudate, and is compatible with cancer |
Ratio pleural/serum proteins | 0.68 (> 0.5) |
Ratio pleural/serum proteins | 0.65 (> 0.6) |
Pleural effusion lactate dehydrogenase > 2/3 upper limit of normal | No |
- Citation: Martin Huertas R, Fuentes-Mateos R, Serrano Domingo JJ, Corral de la Fuente E, Rodríguez-Garrote M. Albumin-bound paclitaxel as new treatment for metastatic cholangiocarcinoma: A case report. World J Clin Oncol 2020; 11(10): 844-853
- URL: https://www.wjgnet.com/2218-4333/full/v11/i10/844.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i10.844